Energy Transfer Therapy in Treatment of Medial Gastrocnemius

NCT04325750 | Completed

• 1 other identifier: UCV2017-2018-40
• Study Type: interventional
• Target: 32
• Locations: 1 country
• Sites: 1

Brief Summary

This study develops the effects of Capacitive and Resistive Energy Transfer Therapy (TECAR) on medial gastrocnemius using thermographic cameras, algometry and lunge tests, in a pre-post study with basketball players using a control group to which placebo is applied. (simulated technique) and an intervention group to which the technique is performed. The main objective of the study is to establish whether the TECAR produces physiological and mechanical changes in the subjects that improve muscle recovery.

Conditions

Strain of Gastrocnemius Muscle (Diagnosis); Diathermy Plate Burn; Thermography; Sports Physical Therapy

Outcome Measures

Primary Outcomes (1)

• Pain intensity

  Visual analogue scale (VAS) of pain

  30 minutes

Secondary Outcomes (2)

• Back flexion

  30 minutes

• Thermographic evaluation

  30 minutes

Study Arms (2)

Control

PLACEBO COMPARATOR

The simulated mode technique is applied (machine off)

Other: Placebo

TECAR THERAPY

EXPERIMENTAL

The intervention will be performed with the T-Care TECAR® therapy machine at the latent trigger points of both gastrocnemius. The professional will apply the therapy with the generator that emits radio frequency signals of 0.5 MHz at a variable power with a maximum of 300W. The frequency to be used will be 500MHz with an intensity of 40% and with direct current.

Procedure: TECAR Therapy

Interventions

TECAR Therapy PROCEDURE

The intervention will be performed with the T-Care TECAR® therapy machine at the latent trigger points of both gastrocnemius. The professional will apply the therapy with the generator that emits radio frequency signals of 0.5 MHz at a variable power with a maximum of 300W. The frequency to be used will be 500MHz with an intensity of 40% and with direct current.

TECAR THERAPY

Placebo OTHER

simulated TECAR Therapy (machine off)

Control

Eligibility Criteria

• Age: 16 Years - 39 Years
• Sex: male
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Male players
• Semi-professional players who are currently active
• Not have suffered a lower limb injury in the last 6 months before the study
• Not having suffered a rupture of the triceps surae
• Contain a latent trigger point in the medial gastrocnemius

You may not qualify if:

• Players suffering from any disease that could alter the study or be contradictory

Sponsors & Collaborators

• Fundación Universidad Católica de Valencia San Vicente Mártir: lead

Study Sites (1)

Universidad Católica de Valencia San Vicente Mártir

Valencia, 46001, Spain

Location

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Carlos Barrios, PhD

  Universidad Católica de Valencia San Vicente Mártir

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD. Dean of Faculty of Medicine and Health Sciences

Study Record Dates

• First Submitted: March 23, 2020
• First Posted: March 30, 2020
• Study Start: June 1, 2018
• Primary Completion: August 28, 2020
• Study Completion: August 28, 2020
• Last Updated: September 29, 2020

Record last verified: 2020-09

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)